Neurosurgical Review

, Volume 7, Issue 4, pp 303–312 | Cite as

Magnetic resonance tomography (MRT) of intracranial tumours: Initial experience with the use of the contrast medium gadolinium-DTPA

  • Wolfgang Schörner
  • Ekkehard Kazner
  • Michael Laniado
  • Christian Sprung
  • Roland Felix
II. Nuclear magnetic resonance tomography

Summary

The present study provides an introduction to the clinical diagnosis of intracranial lesions by means of magnetic resonance tomography (MRT). The demonstration of different tissue qualities (bone and bone marrow, cerebral cortex and medulla, ventricular system (CSF), blood, tumour and perifocal oedema) in the MR tomogram is explained. The principles of specific MRT contrast media and their clinical application in brain tumours are discussed in detail.

Keywords

Cerebral tumour contrast media Gadolinium-DTPA magnetic resonance tomography (MRT) oedema 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Bradley, W. G., R. A. Yadley, R. R. Wycoff: The appearance of different forms of brain edema on NMR. Society of Magnetic Resonance in Medicine. San Francisco (1983) Aug. 16–19Google Scholar
  2. [2]
    Brant-Zawadzki, M., P. L. Davis, L. E. Crooks, et al.: NMR demonstration of cerebral abnormalities: comparison with CT, AJR 140 (1983) 847–854PubMedGoogle Scholar
  3. [3]
    Brant-Zawadzki, M., J. P. Badami, C. M. Mills, et al.: Primary intracranial tumor imaging: a comparison of magnetic resonance and CT. Radiology 150 (1984) 435–440PubMedGoogle Scholar
  4. [4]
    Brant-Zawadzki, M., C. M. Mills, D. Norman: Central nervous system. In: (Edit.) Margulis, A. R., C. B. Higgins, L. Kaufman, et al.: Clinical magnetic resonance imaging. Radiology Research and Education Foundation. San Francisco (1983) p. 91Google Scholar
  5. [5]
    Bydder, G. M., R. E. Steiner, I. R. Young, et al.: Clinical imaging of the brain: 140 cases AJR 139 (1982) 215–236PubMedGoogle Scholar
  6. [6]
    Claussen, C., M. Laniado, E. Kazner, et al.: Application of contrast agents in CT and NMR: their potential in imaging of brain tumors. Neuroradiology (1984) (accepted for publication)Google Scholar
  7. [7]
    Carr, D. H., J. Brown, G. M. Bydder, et al.: Clinical use of intravenous Gadolinium-DTPA as a contrast agent in NMR imaging of cerebral tumours. Lancet 1 (1984) 484–486PubMedGoogle Scholar
  8. [8]
    Damadian, R.: Tumour detection by NMR. Science 171 (1971) 1151–1153PubMedGoogle Scholar
  9. [9]
    Doyle, F. H., J. C. Gore, J. M. Pennock, et al.: Imaging of the brain by nuclear magnetic resonance. Lancet 2 (1981) 53–57PubMedGoogle Scholar
  10. [10]
    Johnson, M. A., J. M. Pennock, G. M. Bydder, et al.: Clinical NMR imaging of the brain in children: normal and neurologic disease. AJR 141 (1983) 1005–1018PubMedGoogle Scholar
  11. [11]
    Kazner, E., S. Wende, T. Grumme, et al.: Computed tomography in intracranial tumours. Springer, Berlin — Heidelberg — New York 1982Google Scholar
  12. [12]
    Margulis, A. R.: The role of magnetic resonance imaging in medicine. In: Margulis, A. R., C. B. Higgins, L. Kaufman, et al.: (Edit.) Clinical magnetic resonance imaging. Radiology Research and Education Foundation, San Francisco 1983, p. 1Google Scholar
  13. [13]
    Mills, C. M., L. E. Crooks, L. Kaufman, et al.: Cerebral abnormalities: use of calculated T1 and T2 magnetic resonance images for diagnosis. Radiology 150 (1984) 87–94PubMedGoogle Scholar
  14. [14]
    Mills, C. M., J. de Groot: Anatomic approach to nuclear magnetic resonance images of the brain. In: Margulis, A. R., C. B. Higgins, L. Kaufman, et al.: (Edit.) Clinical magnetic resonance imaging, Radiology Research and Education Foundation. San Francisco 1983, p. 81Google Scholar
  15. [15]
    Pople, J. A., W. G. Schneider, H. J. Bernstein: Highresolution nuclear magnetic resonance. McGraw-Hill Book Company Inc., New York — Toronto — London 1959, 209–217Google Scholar
  16. [16]
    Pykett, I. L., F. S. Buonanno, T. J. Brady, et al.: Techniques and approaches to proton NMR imaging of the head. Computerized Radiol. 7 (1983) 1–17Google Scholar
  17. [17]
    Schörner, W., R. Felix, M. Laniado, et al.: Prüfung des kernspintomographischen Kontrastmittels Gadolinium-DTPA am Menschen. Fortschr. Röntgenstr. 140 (1984) 493–500Google Scholar
  18. [18]
    Schörner, W., R. Felix, C. Claussen, et al.:Kernspintomographische Diagnostik von Hirntumoren mit dem Kontrastmittel Gadolinium-DTPA. Fortschr. Röntgenstr. (1984) (Accepted for publication)Google Scholar
  19. [19]
    Singer, J. R., L. E. Crooks: Some magnetic studies of normal and leukemic blood. J. Clin. Eng. 3 (1978) 237–241Google Scholar
  20. [20]
    Weinmann, H. J., R. C. Brasch, W. R. Press, et al.: Characteristics of Gadolinium-DTPA complex: a potential NMR contrast agent. AJR 142 (1984) 619–624PubMedGoogle Scholar
  21. [21]
    Young, I. R., M. Burl., G. J. Clarke: Magnetic resonance properties of hydrogen: imaging the posterior fossa. AJR 137 (1981) 895–901PubMedGoogle Scholar
  22. [22]
    Young, J. R., A. S. Hall, C. A. Pallis, et al.: Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lacet 2 (1981) 1063–1066Google Scholar

Copyright information

© Walter de Gruyter & Co. 1984

Authors and Affiliations

  • Wolfgang Schörner
    • 1
    • 3
  • Ekkehard Kazner
    • 1
    • 2
  • Michael Laniado
    • 1
  • Christian Sprung
    • 1
    • 2
  • Roland Felix
    • 1
  1. 1.Departments of RadiologyKlinikum Charlottenburg, The Free University of BerlinF.R. Germany
  2. 2.Departments of NeurosurgeryKlinikum Charlottenburg, The Free University of BerlinF.R. Germany
  3. 3.Radiologische Klinik und PoliklinikKlinikum Charlottenburg, FU BerlinBerlin 19F. R. Germany

Personalised recommendations